ABSTRACT. Mycoplasma hyopneumoniae (M. hyopneumoniae) causes porcine enzootic pneumonia (PEP) that significantly affects the pig industry worldwide. Despite the availability of the whole genome sequence, studies on the pathogenesis of this organism have been limited due to the lack of a genetic manipulation system. Therefore, the aim of the current study was to generate a general GFP reporter vector based on a replicating plasmid. Here, we describe the feasibility of GFP reporter expression in M. hyopneumoniae (strain 168L) controlled by the p97 gene promoter of this mycoplasma. An expression plasmid (pMD18-TOgfp) containing the p97 gene promoter, and origin of replication (oriC) of M. hyopneumoniae, tetracycline resistant marker (tetM), and GFP was constructed and used to transform competent M. hyopneumoniae cells. We observed green fluorescence in M. hyopneumoniae transformants under fluorescence microscopy, which indicates that there was expression of the GFP reporter that was driven by the p97 gene promoter. Additionally, an electroporation method for M. hyopneumoniae with an -6 transformants/µg plasmid DNA was optimized and is described herein. In conclusion, our data demonstrate the susceptibility of M. hyopneumoniae to genetic manipulation whereby foreign genes are expressed. This work may encourage the development of genetic tools to manipulate the genome of M. hyopneumoniae for functional genomic analyses.
INTRODUCTION
Mycoplasma hyopneumoniae (M. hyopneumoniae) causes porcine enzootic pneumonia (PEP) that affects the pig industry worldwide. Although the mortality rate of this disease is low, the incidence has remained high. Once an outbreak is established, the control of the disease is difficult, resulting in significant economic losses (DeBey et al., 1992; DeBey and Ross, 1994) . M. hyopneumoniae infection is often complicated by secondary bacterial and viral infections such as those of Pasteurella multocida, Streptococcus suis, Haemophilus parasuis, Porcine reproductive and respiratory syndrome virus (PRRSV), and Porcine circovirus 2 (PCV-2). Currently, control of M. hyopneumoniae induced PEP mainly depends on antibiotics and vaccines. Although the current vaccine can protect against M. hyopneumoniae infection, methods to control the disease are still lacking. Therefore, the development of more efficient therapeutic approaches is urgently needed.
Recently, the whole genome sequence of M. hyopneumoniae strain 168L was determined (Liu et al., 2011) . More recently, Maglennon et al. (2013a; 2013b) established methods to transform M. hyopneumoniae strain 232 with oriC-plasmids, and suggested the use of transposon mutagenesis to establish libraries of random mutations in this strain. Therefore, evidence supporting the use of M. hyopneumoniae as a host for heterologous gene expression has become a prerequisite for genetic studies regarding the pathogenicity of this organism, as the complementation of mutants requires the cloning and expression of exogenous genes.
Expression of reporter systems such as the lacZ gene and green fluorescent protein (GFP) in mycoplasmas can help to understand the nature of gene expression in these bacteria. However, in all reported cases, the fluorescent fusion proteins were constructed in standard cloning vectors, and subsequently transferred to mycoplasma transposon delivery vectors (Balish et al., 2003; Kenri et al., 2004; Zimmerman and Herrmann, 2005) . Therefore, it would be helpful to have a general GFP reporter plasmid that was developed based on a replicating plasmid.
In the current study, an expression plasmid pMD18-TOgfp was constructed, in which the p97 gene promoter was used to express reporter GFP in M. hyopneumoniae strain 168L. The method of electro-transformation of M. hyopneumoniae was also optimized. The motivation for this work was that obtaining an expression vector for M. hyopneumoniae based on replicating plasmids may help to develop genetic tools to engineer the M. hyopneumoniae genome.
MATERIAL AND METHODS

Bacterial strains and growth conditions
at 37°C in KM2 cell-free liquid medium (a modified Friis medium) containing 20% (v/v) swine serum as previously described (Bai et al., 2013) . For growth on solid medium, a final concentration of 0.7% w/v purified agar was added to the KM2 medium, and plates were incubated at 37°C until colonies were visible. Colonies were visualized by light microscopy. For the selection of transformed M. hyopneumoniae, tetracycline hydrochloride (SigmaAldrich, St. Louis, MO, USA) was added to a final concentration of 0.02 mg/mL. The E. coli competent cells, XL-10 (Vazyme, Nanjing, China) served as the host for cloning procedures and plasmid amplification, and were grown in Luria-Bertani (LB) broth containing 100 mg/mL ampicillin at 37°C with overnight shaking at 180 rpm.
Vector construction
The primers for the target genes listed in Table 1 were designed based on the sequences available in the National Center for Biotechnology Information (NCBI) GenBank database (M. hyopneumoniae strain 168L ID 507382422; tetM ID AGI19285.1; and GFP ID AGN96197.1). The origin of replication (oriC) of M. hyopneumoniae was predicted based on previously described methods (Cordova et al., 2002; Maglennon et al., 2013b) , as was the p97 gene promoter (Maglennon et al., 2013b) . Touchdown PCR was performed with the Ex Taq Polymerase Kit (TaKaRa, Otsu, Japan) to obtain the target genes. The oriC and p97 gene promoter were PCR amplified from M. hyopneumoniae 168L genomic DNA, while GFP and tetM were PCR amplified from the pSE-1 plasmid (provided by Prof. Xiao Shaobo of Huazhong Agricultural University, Wuhan, China).
The pMD18-T vector (TaKaRa) was used to construct the expression vector of M. hyopneumoniae, and the cloning sites for insertion of the target fragments into this vector were as follows: the oriC at EcoRI/XhoI sites, the p97 gene promoter at SacI/BamHI sites, tetM at BamHI/XbaI sites, and the p97 gene promoter spliced with GFP at SalI/PstI sites. The resultant plasmid was designated as pMD18-TOgfp. Every cloned fragment was verified by restriction enzyme digestion and DNA sequencing analysis.
Electroporation of M. hyopneumoniae
Electroporation of M. hyopneumoniae was done according to previously published methods with minor modifications (Maglennon et al., 2013b) . Briefly, approximately 40 mL cultured M. hyopneumoniae were centrifuged at 12,000 rpm for 20 min at 4°C, and the *Restriction enzyme sites are in bold and underlined. MHP = M. hyopneumoniae. F = forward, R = reverse. 2) supplemented with 1 mM EDTA. The pellet was incubated on ice for 5 min, and then resuspended in 100 µL electroporation buffer. This preparation of competent M. hyopneumoniae cells was either transformed immediately or stored at -80°C. Plasmid DNA (10-15 mg) was added to 100 mL competent cells and transferred to a chilled 0.2 cm electroporation cuvette (Bio-Rad, Hercules, CA, USA). The mixture was incubated on ice for 20 min. The cells were electroporated with the ECM 630 Electroporation System (Harvard Apparatus BTX, Holliston, MA, USA) at 2.5 KV, 125 W, and 25 mF. Immediately after electroporation, 900 mL chilled KM2 medium was added. To this mixture, an additional 10 mg pMD18-TOgfp plasmid was inoculated. The resulting suspension was incubated for 20 min on ice, and then 24 h at 37°C. Subsequently, 0.02 mg/mL tetracycline hydrochloride (minimum inhibitory concentration) was added, and the cells were incubated at 37°C for 5-10 days. The selected transformants were also grown in KM2-Agar for at least for 2 weeks.
PCR-based detection of GFP in selected transformants
M. hyopneumoniae DNA was extracted from 2 mL cultures using a genomic DNA purification kit (TIANGEN, Beijing, China). PCR amplification of the GFP gene was performed to detect the presence of the pMD18-TOgfp plasmid in the selected KM2 transformants using GFP specific primers. The resultant product was 750 bp.
Detection of GFP fluorescence
The M. hyopneumoniae transformants grown in KM2 containing 0.02 mg/mL tetracycline hydrochloride were then plated on KM2-Agar and cultured until the growth of visible colonies. The GFP fluorescence of single M. hyopneumoniae clones was observed under a fluorescent microscope (Nikon, Eclipse E600, Tokyo, Japan).
RESULTS
Vector construction
In the current study, the fragments (GFP, tetM, oriC, and p97 gene promoter) required to construct the heterologous gene expression vector for M. hyopneumoniae were PCR amplified ( Figure 1A) , and cloned into the pMD18-T vector to yield the desired pMD18-TOgfp vector ( Figure 1B) .
Electroporation of M. hyopneumoniae
The constructed expression plasmid isolated from E. coli could be introduced into M. hyopneumoniae competent cells by electroporation. The electric field, electric resistance, and amount of DNA required for the transformation were then optimized. Accordingly, 1 x 10 -6 transformants·CFU -1 ·mg -1 plasmid DNA were obtained with an electroporation system under optimal conditions (2.5 KV/cm, 100 W, 25 mF). Adding up to 10 mg plasmid DNA to cells immediately after electroporation improved the transformation efficiency where the colonies appeared within 10-14 days of incubation.
PCR-based detection of GFP in selected transformants
Total DNA was extracted from pooled M. hyopneumoniae transformants grown in KM2 medium containing 0.02 µg/mL tetracycline hydrochloride, and the presence of the pMD18-TOgfp plasmid was subsequently analyzed by PCR detection of GFP (750 bp). Sequence analyses of the transformants further showed that the amplified products contained GFP DNA (Figure 2 ), which correlated with GFP expression observed under fluorescence microscopy. GFP was not detected in DNA from untransformed bacteria.
Detection of GFP fluorescence
The promoter of the p97 gene of M. hyopneumoniae 168L was used to express the reporter genes including GFP. Cells were transformed with the pMD18-TOgfp plasmid, grown in KM2 containing 0.02 µg/mL tetracycline hydrochloride, and plated in KM2-Agar. The cells were then cultured at 37°C for 14 days. The presence of GFP was observed under fluorescence microscopy in the transformed colonies (Figure 3 ), but not in controls, indicating that GFP was expressed and functional in M. hyopneumoniae. 
DISCUSSION
M. hyopneumoniae is one of the most important species of mycoplasmas. M. hyopneumoniae-induced PEP negatively affects the pig industry worldwide. Although the mortality rate of the disease is low, the incidence has remained high. Once an outbreak is established, the control of the disease is difficult, and thus can result in significant economic losses (DeBey et al., 1992; DeBey and Ross, 1994) .
The lack of development of tools for M. hyopneumoniae 168L genetic manipulation has been a major obstacle in studies into the pathogenesis of this organism for several years. The slow growth of this pathogen in liquid medium, difficultly of growth in solid medium, and its resistance to accept foreign genes by standard transformation methods have further complicated the development of genetic tools for functional genomics studies of M. hyopneumoniae 168L. With the exception of two reports by the British authors describing a replicative plasmid and transposon tool for M. hyopneumoniae strain 232 (Maglennon et al., 2013a; Maglennon et al., 2013b) , little progress has been made in this area. Therefore, evidence supporting the use of M. hyopneumoniae as a host for heterologous gene expression is important as the complementation of bacterial mutants requires the expression of exogenous genes.
Recently, the entire genome of M. hyopneumoniae strain 168L was sequenced (Liu et al., 2011) , which has provided a large amount of useful data. Herein, we aimed to investigate the expression of the GFP reporter in M. hyopneumoniae transformed with a vector based on replicative plasmids. The origin of replication has been used to develop oriC-plasmids in some mycoplasmas (Cordova et al., 2002; Chopra-Dewasthaly et al., 2005; Janis et al., 2005; Lee et al., 2008) ., which in turn has been used to inactivate targeted genes (Cordova et al., 2002; Lee et al., 2008) . The origin of replication in mycoplasma is generally located around the dnaA gene (Cordova et al., 2002) . Following this, the oriC of M. hyopneumoniae was previously identified. Therefore, for the first time, we cloned this oriC into the pMD18-T vector along with a tetracycline resistance marker for selection and GFP for the first time to monitor heterologous gene expression. We used the M. hyopneumoniae p97 gene promoter to heterologously express the GFP reporter gene in M. hyopneumoniae, and optimized methods for electro-transformation these mycoplasma. With this construct, GFP fluorescence was obtained, indicating that the expression of heterologous genes in M. hyopneumoniae is feasible.
In conclusion, we generated a general GFP reporter plasmid for M. hyopneumoniae based on a replicating plasmid that may be used as a tool to engineer the genome of M. hyopneumoniae, and thus can be used to better understand its pathogenesis.
